With more Covid-19 cases reported in the first five months of 2021 than in the whole of 2020 and the fear that hard-won gains of the last three months are at risk, the ACT-Accelerator has mounted a $7.7bn funding appeal, including $1.2bn to rapidly address acute oxygen needs.